September 2024 Venture Growth Funding Recap

In August 2024, Growthink Capital Research reported new venture funding of $4.78 billion, compared to $7.77 billion recorded in July 2024.

The month’s biggest funding event belonged to Groq ($640 million), an AI interface technology designed to address the industry’s demands of computing speed, quality, and energy efficiency enabling companies to improve workloads in artificial intelligence and quality-performance computing.

Twelve companies raised $100 million in August. Other than Groq, the other eleven companies that raised the most are as follows:

  1. Cribl ($319 million) a big data software designed to simplify big data and log analytics at scale enabling businesses to get observability, intelligence, and control over their real-time data.

  2. Grafana Labs ($270 million) a performance monitoring platform designed to support organizations’ visualization and observability goals enabling firms to take control of their unified monitoring and avoid vendor lock-in and the spiraling costs of closed resolutions.

  3. Abnormal Security ($250 million) a cloud email security platform intended to prevent cyber-crimes enabling businesses to prevent direct attacks on their confidential data.

  4. Caresyntax ($180 million) a data-driven surgical analysis platform intended to improve patient outcomes enabling healthcare businesses to gain insights that can be used live during surgery, for post-surgical improvement, resource optimization, product development, and risk assessment.

  5. Codeium ($150 million) a deep learning acceleration platform designed to simplify and accelerate complex artificial intelligence workloads enabling clients to integrate accelerated deep learning into an interactive or batch application.

  6. Scorpion Therapeutics ($150 million) a biotechnology company intended to expand the reach of precision medicine to more people with cancer enabling healthcare professionals to treat cancer patients with novel treatments.

  7. Halda Therapeutics ($126 million) a drug discovery platform designed to create therapeutic and precision medicines enabling healthcare providers to treat their patients based on a novel therapeutic modality.

  8. CloudPay ($120 million) a cloud-based payroll platform intended to deliver end-to-end payroll management services to multinational organizations, enabling organizations to increase efficiency, streamline compliance, and achieve greater visibility into payroll performance and costs.

  9. Histosonics ($102 million) a novel, non-invasive sonic beam therapy platform designed to liquefy and destroy targeted tissues at a sub-cellular level enabling physicians to monitor the treatment and its effect in real-time continuously.

  10. Navigator Medicines ($100 million) an autoimmune disease treatment intended to advance biologics for targeted immune regulation and restoration enabling the medical staff to treat and care for patients with autoimmune diseases.

  11. DevRev ($100 million) an artificial intelligence-native platform designed to streamline product development and customer service enabling clients to boost their productivity through the products.

The hottest sectors for funding during the month were A.I./Machine Learning, Biotech, Financial Software, Business/Productivity Software, and Cybersecurity.

Key funding events in each of these sectors for the month are below:

  1. A.I./Machine Learning deals included Codeium ($150 million), DevRev ($100 million), EliseAI ($75 million), Onebrief ($53 million), Defcon AI ($44 million), Sahara AI ($43 million), Guidewheel ($31 million), Encord ($30 million), Bland AI ($16 million), Levitate ($15 million), Datch ($15 million), Uptime AI ($14 million), Aurascape AI ($12.8 million), ModelOp ($10 million), BeyondMath ($8.5 million), and Ragie ($5.5 million).

  2. Biotech deals included Scorpion Therapeutics ($150 million), Halda Therapeutics ($126 million), Navigator Medicines ($100 million), MBX Biosciences ($64 million), Gro Biosciences ($60 million), Amlogenyx ($14 million), NeuroTherapia ($12.3 million), Botanical Solution ($7.6 million), and Kano Therapeutics ($7.1 million).

  3. Financial Software deals included CloudPay ($120 million), Siepe ($30 million), Amount ($30 million), Savvy Wealth ($26.5 million), Comun ($21.5 million), and Lettuce Financial ($15 million).

  4. Business/Productivity Software deals included Grafana Labs ($270 million), Cents ($40 million), Eppo ($28 million), Supio ($25 million), and ITpipes ($20 million).

  5. Cybersecurity deals included Abnormal Security ($250 million), Protect AI ($60 million), Chaos Labs ($55 million), Anjuna ($25 million), and Actuate ($11.5 million).

If you’re looking for outside funding to grow your company, please don’t hesitate to call us at (213) 927-3968 or fill out Growthink Capital’s contact form here.